Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation (Q39063423)

8 September 2017

title

Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation (English)

1 reference

8 September 2017

7

1 reference

Bárbara Cristina Martins Fernandes Paes

8 September 2017

1

0 references

Pablo Diego Moço

Cristiano Gonçalves Pereira

2

0 references

object named as

Cristiano Gonçalves Pereira

3

0 references

Geciane Silveira Porto

object named as

Geciane Silveira Porto

4

0 references

author name string

Elisa Maria de Sousa Russo

5

1 reference

8 September 2017

Luiza Cunha Junqueira Reis

6

1 reference

8 September 2017

Virginia Picanço-Castro

8

1 reference

8 September 2017

publication date

30 December 2016

1 reference

Cell Biology and Toxicology

8 September 2017

published in

1 reference

8 September 2017

volume

33

1 reference

8 September 2017

issue

3

1 reference

8 September 2017

page(s)

233-250

1 reference

Transplantation of Macaca cynomolgus iPS-derived hematopoietic cells in NSG immunodeficient mice

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Pluripotent stem cells in disease modelling and drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Variable behavior of iPSCs derived from CML patients for response to TKI and hematopoietic differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Breaking the code of DNA binding specificity of TAL-type III effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Prolonged ex vivo culture of human bone marrow mesenchymal stem cells influences their supportive activity toward NOD/SCID-repopulating cells and committed progenitor cells of B lymphoid and myeloid lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Activin A promotes hematopoietic fated mesoderm development through upregulation of brachyury in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Induced pluripotent stem cells with a mitochondrial DNA deletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Targeted correction of RUNX1 mutation in FPD patient-specific induced pluripotent stem cells rescues megakaryopoietic defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Erythroid differentiation of human induced pluripotent stem cells is independent of donor cell type of origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Mesenchymal stromal cells enhance the engraftment of hematopoietic stem cells in an autologous mouse transplantation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

β-Globin-Expressing Definitive Erythroid Progenitor Cells Generated from Embryonic and Induced Pluripotent Stem Cell-Derived Sacs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

RIKEN suspends first clinical trial involving induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Dysregulation of the Transforming Growth Factor β Pathway in Induced Pluripotent Stem Cells Generated from Patients with Diamond Blackfan Anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Assessing the safety of stem cell therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Vascular niche promotes hematopoietic multipotent progenitor formation from pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Homing endonucleases: DNA scissors on a mission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Congenital amegakaryocytic thrombocytopenia iPS cells exhibit defective MPL-mediated signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Generation of induced pluripotent stem cells derived from primary and secondary myelofibrosis patient samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Blood group genotyping by high-throughput DNA analysis applied to 356 reagent red blood cell samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Hematopoietic colony-forming cells derived from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Hematopoietic commitment during embryonic stem cell differentiation in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Hematopoietic development from human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Directed differentiation of embryonic stem cells to the T-lymphocyte lineage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Generation of induced pluripotent stem cells from human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Reprogramming of T cells from human peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Transcription activator-like effector nuclease (TALEN)-mediated gene correction in integration-free β-thalassemia induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Patents and misplaced angst: lessons for translational stem cell research from genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Genetic correction of HAX1 in induced pluripotent stem cells from a patient with severe congenital neutropenia improves defective granulopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Myeloid Dysregulation in a Human Induced Pluripotent Stem Cell Model of PTPN11-Associated Juvenile Myelomonocytic Leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Pathogenesis of ELANE-mutant severe neutropenia revealed by induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Epigenetic variation between human induced pluripotent stem cell lines is an indicator of differentiation capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Combining Single Strand Oligodeoxynucleotides and CRISPR/Cas9 to Correct Gene Mutations in β-Thalassemia-induced Pluripotent Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Large-scale production of embryonic red blood cells from human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: potential applications for alloimmunized patients and rare blood challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Preclinical safety of human embryonic stem cell-derived oligodendrocyte progenitors supporting clinical trials in spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Genome engineering using the CRISPR-Cas9 system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

The global intellectual property landscape of induced pluripotent stem cell technologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Clinical-scale purification of pluripotent stem cell derivatives for cell-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Engineering Hematopoietic Stem Cells: Lessons from Development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

A comparison of non-integrating reprogramming methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

The zinc finger nuclease monopoly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

The safety of human pluripotent stem cells in clinical treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR/Cas9 system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Reprogramming of human peripheral blood cells to induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Derivation and propagation of human embryonic stem cell lines from frozen embryos in an animal product-free environment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Conformational control of DNA target cleavage by CRISPR-Cas9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Seamless correction of the sickle cell disease mutation of the HBB gene in human induced pluripotent stem cells using TALENs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Generation of T cells from human embryonic stem cell-derived hematopoietic zones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Brief Report: Immune Microenvironment Determines the Immunogenicity of Induced Pluripotent Stem Cell Derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Pluripotent stem cell models of Shwachman-Diamond syndrome reveal a common mechanism for pancreatic and hematopoietic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Red cell alloimmunization in multi-transfused patients with sickle cell anemia in Benin City, Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

In vitro human embryonic stem cell hematopoiesis mimics MYB-independent yolk sac hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Regeneration of human tumor antigen-specific T cells from iPSCs derived from mature CD8(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

Induced pluripotent stem cell lines derived from human somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9377-2

10.1007/S10565-016-9377-2

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference